| scholarly article | Q13442814 |
| P50 | author | Md. Asaduzzaman Khan | Q43143468 |
| Mousumi Tania | Q52280436 | ||
| P2093 | author name string | Xianning Zhang | |
| Junjiang Fu | |||
| Xiuli Xiao | |||
| Xianqin Zhang | |||
| Saber Imani | |||
| Chunli Wei | |||
| Jingliang Cheng | |||
| Luquan Yang | |||
| Shangyi Fu | |||
| P2860 | cites work | Molecular mechanisms of epithelial-mesenchymal transition | Q27013743 |
| TGF-β1-induced EMT promotes targeted migration of breast cancer cells through the lymphatic system by the activation of CCR7/CCL21-mediated chemotaxis | Q27310034 | ||
| Cancer statistics, 2014 | Q27861018 | ||
| Twist, a master regulator of morphogenesis, plays an essential role in tumor metastasis | Q28131703 | ||
| The miR-34 family in cancer and apoptosis | Q28245865 | ||
| Thymoquinone inhibits cancer metastasis by downregulating TWIST1 expression to reduce epithelial to mesenchymal transition | Q28262567 | ||
| Inactivation of miR-34a by aberrant CpG methylation in multiple types of cancer | Q28291502 | ||
| Twist: a molecular target in cancer therapeutics | Q28294941 | ||
| Allelic losses at 1p36 and 19q13 in gliomas: correlation with histologic classification, definition of a 150-kb minimal deleted region on 1p36, and evaluation of CAMTA1 as a candidate tumor suppressor gene | Q28307186 | ||
| A perspective on cancer cell metastasis | Q28307891 | ||
| Targeting epigenetic regulation of miR-34a for treatment of pancreatic cancer by inhibition of pancreatic cancer stem cells | Q28476781 | ||
| Thymoquinone inhibits tumor growth and induces apoptosis in a breast cancer xenograft mouse model: the role of p38 MAPK and ROS | Q28534004 | ||
| Snail, Zeb and bHLH factors in tumour progression: an alliance against the epithelial phenotype? | Q29547559 | ||
| MicroRNA-34a inhibits glioblastoma growth by targeting multiple oncogenes | Q30434616 | ||
| The neuronal microRNA miR-326 acts in a feedback loop with notch and has therapeutic potential against brain tumors | Q30435946 | ||
| An online survival analysis tool to rapidly assess the effect of 22,277 genes on breast cancer prognosis using microarray data of 1,809 patients | Q33519584 | ||
| Epigenetic regulation of epithelial-mesenchymal transition | Q33764436 | ||
| Wnt/beta-catenin pathway activation is enriched in basal-like breast cancers and predicts poor outcome. | Q33882525 | ||
| MicroRNA-34a suppresses invasion through downregulation of Notch1 and Jagged1 in cervical carcinoma and choriocarcinoma cells. | Q34107306 | ||
| TNFalpha up-regulates SLUG via the NF-kappaB/HIF1alpha axis, which imparts breast cancer cells with a stem cell-like phenotype | Q34130168 | ||
| Epithelial-mesenchymal transition in human cancer: comprehensive reprogramming of metabolism, epigenetics, and differentiation | Q34458518 | ||
| Evaluation of HER2 status: for the treatment of metastatic breast cancers by humanized anti-HER2 Monoclonal antibody (trastuzumab) (Pathological committee for optimal use of trastuzumab). | Q34494017 | ||
| miR-142 regulates the tumorigenicity of human breast cancer stem cells through the canonical WNT signaling pathway | Q34529305 | ||
| p53 regulates epithelial-mesenchymal transition through microRNAs targeting ZEB1 and ZEB2. | Q34973748 | ||
| The TWIST/Mi2/NuRD protein complex and its essential role in cancer metastasis | Q35348193 | ||
| Dynamic actin remodeling during epithelial-mesenchymal transition depends on increased moesin expression. | Q35612241 | ||
| MicroRNA-34a suppresses the breast cancer stem cell-like characteristics by downregulating Notch1 pathway | Q35754283 | ||
| Thymoquinone induces apoptosis in oral cancer cells through p38β inhibition | Q39147015 | ||
| Antitumor and anti-angiogenesis effects of thymoquinone on osteosarcoma through the NF-κB pathway | Q39227616 | ||
| MicroRNA-34 suppresses breast cancer invasion and metastasis by directly targeting Fra-1. | Q39273521 | ||
| MiR-34a inhibits proliferation and migration of breast cancer through down-regulation of Bcl-2 and SIRT1. | Q39343253 | ||
| Twist overexpression induces in vivo angiogenesis and correlates with chromosomal instability in breast cancer | Q40345084 | ||
| The potential role of Brachyury in inducing epithelial-to-mesenchymal transition (EMT) and HIF-1α expression in breast cancer cells | Q40514866 | ||
| YB-1 expression promotes epithelial-to-mesenchymal transition in prostate cancer that is inhibited by a small molecule fisetin | Q40720588 | ||
| PEGylated-thymoquinone-nanoparticle mediated retardation of breast cancer cell migration by deregulation of cytoskeletal actin polymerization through miR-34a | Q41223589 | ||
| Epithelial-mesenchymal transition-associated microRNA/mRNA signature is linked to metastasis and prognosis in clear-cell renal cell carcinoma. | Q41430806 | ||
| MicroRNA-100 suppresses the migration and invasion of breast cancer cells by targeting FZD-8 and inhibiting Wnt/β-catenin signaling pathway. | Q50916076 | ||
| Relationship between SPOP mutation and breast cancer in Chinese population. | Q50966820 | ||
| MiR-34a Inhibits Breast Cancer Proliferation and Progression by Targeting Wnt1 in Wnt/β-Catenin Signaling Pathway. | Q51571859 | ||
| Micro RNA 34a and Let-7a Expression in Human Breast Cancers is Associated with Apoptotic Expression Genes. | Q53094985 | ||
| Downregulation of miR-34a in breast tumors is not associated with either p53 mutations or promoter hypermethylation while it correlates with metastasis. | Q53259995 | ||
| Evaluation of PIK3CA mutations as a biomarker in Chinese breast carcinomas from Western China. | Q55003988 | ||
| Thymoquinone inhibits proliferation in gastric cancer via the STAT3 pathway in vivo and in vitro | Q36001464 | ||
| Honokiol abrogates leptin-induced tumor progression by inhibiting Wnt1-MTA1-β-catenin signaling axis in a microRNA-34a dependent manner. | Q36140810 | ||
| TGF-β-miR-34a-CCL22 signaling-induced Treg cell recruitment promotes venous metastases of HBV-positive hepatocellular carcinoma. | Q36237549 | ||
| Expression of miR-34 is lost in colon cancer which can be re-expressed by a novel agent CDF. | Q36297343 | ||
| DLX4 upregulates TWIST and enhances tumor migration, invasion and metastasis | Q36337130 | ||
| Twist promotes reprogramming of glucose metabolism in breast cancer cells through PI3K/AKT and p53 signaling pathways | Q36413285 | ||
| TQ inhibits hepatocellular carcinoma growth in vitro and in vivo via repression of Notch signaling | Q36544919 | ||
| MicroRNA-1 down-regulates proliferation and migration of breast cancer stem cells by inhibiting the Wnt/β-catenin pathway | Q36561545 | ||
| miR-34a Silences c-SRC to Attenuate Tumor Growth in Triple-Negative Breast Cancer. | Q36586444 | ||
| World Cancer Report 2014. Geneva, Switzerland: World Health Organization, International Agency for Research on Cancer, WHO Press, 2015. | Q36671054 | ||
| miR-125b inhibited epithelial-mesenchymal transition of triple-negative breast cancer by targeting MAP2K7. | Q36891545 | ||
| Prognostic Value of EMT-inducing Transcription Factors (EMT-TFs) in Metastatic Breast Cancer: A Systematic Review and Meta-analysis. | Q37030764 | ||
| Tripartite motif containing 28 (TRIM28) promotes breast cancer metastasis by stabilizing TWIST1 protein. | Q37093164 | ||
| Twist1 and Slug mediate H2AX-regulated epithelial-mesenchymal transition in breast cells | Q37262885 | ||
| Signaling mechanisms of neurite outgrowth induced by the cell adhesion molecules NCAM and N-cadherin | Q37268922 | ||
| MiR-34a is up-regulated in response to low dose, low energy X-ray induced DNA damage in breast cells | Q37313006 | ||
| An EMT spectrum defines an anoikis-resistant and spheroidogenic intermediate mesenchymal state that is sensitive to e-cadherin restoration by a src-kinase inhibitor, saracatinib (AZD0530). | Q37357076 | ||
| Use of the metastatic breast cancer progression (MBC-P) questionnaire to assess the value of progression-free survival for women with metastatic breast cancer | Q37374245 | ||
| MicroRNA-34a suppresses cell proliferation by targeting LMTK3 in human breast cancer mcf-7 cell line | Q37395296 | ||
| MiR-155-mediated loss of C/EBPβ shifts the TGF-β response from growth inhibition to epithelial-mesenchymal transition, invasion and metastasis in breast cancer | Q37501803 | ||
| WASF3 regulates miR-200 inactivation by ZEB1 through suppression of KISS1 leading to increased invasiveness in breast cancer cells | Q37720633 | ||
| A Wnt-ow of opportunity: targeting the Wnt/beta-catenin pathway in breast cancer | Q37764882 | ||
| Is the epithelial-to-mesenchymal transition clinically relevant for the cancer patient? | Q37862294 | ||
| Anticancer activities of Nigella sativa (black cumin) | Q38023389 | ||
| Mir-34: a new weapon against cancer? | Q38253374 | ||
| Twist-1 up-regulation in carcinoma correlates to poor survival | Q38271986 | ||
| Breast Cancer: Epidemiology and Etiology | Q38301683 | ||
| ZEB1 drives prometastatic actin cytoskeletal remodeling by downregulating miR-34a expression | Q38323022 | ||
| Thymoquinone Pretreatment Overcomes the Insensitivity and Potentiates the Antitumor Effect of Gemcitabine Through Abrogation of Notch1, PI3K/Akt/mTOR Regulated Signaling Pathways in Pancreatic Cancer | Q38945152 | ||
| Thymoquinone inhibits proliferation and invasion of human nonsmall-cell lung cancer cells via ERK pathway | Q38954969 | ||
| Regulation of epithelial-mesenchymal transition through microRNAs: clinical and biological significance of microRNAs in breast cancer. | Q38958559 | ||
| Luteolin Induces Apoptosis by Up-regulating miR-34a in Human Gastric Cancer Cells | Q38978767 | ||
| miRNA-34a suppresses cell proliferation and metastasis by targeting CD44 in human renal carcinoma cells | Q38991056 | ||
| Molecular targeting of Akt by thymoquinone promotes G(1) arrest through translation inhibition of cyclin D1 and induces apoptosis in breast cancer cells. | Q39094687 | ||
| P433 | issue | 13 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | cell migration | Q189092 |
| microRNA | Q310899 | ||
| P304 | page(s) | 21362-21379 | |
| P577 | publication date | 2017-03-01 | |
| P1433 | published in | Oncotarget | Q1573155 |
| P1476 | title | MicroRNA-34a targets epithelial to mesenchymal transition-inducing transcription factors (EMT-TFs) and inhibits breast cancer cell migration and invasion | |
| P478 | volume | 8 |
| Q64279774 | An integrated analysis to predict micro-RNAs targeting both stemness and metastasis in breast cancer stem cells |
| Q91965386 | Combating breast cancer using combination therapy with 3 phytochemicals: Piperine, sulforaphane, and thymoquinone |
| Q92083437 | Deciphering the Molecular Basis of Melatonin Protective Effects on Breast Cells Treated with Doxorubicin: TWIST1 a Transcription Factor Involved in EMT and Metastasis, a Novel Target of Melatonin |
| Q41279583 | Development of diagnostic SCAR markers for genomic DNA amplifications in breast carcinoma by DNA cloning of high-GC RAMP-PCR fragments |
| Q57021398 | Epigenetically Distinct Sister Chromatids and Asymmetric Generation of Tumor Initiating Cells |
| Q60960583 | Evaluation of pre-mir-34a rs72631823 single nucleotide polymorphism in triple negative breast cancer: A case-control study |
| Q50181237 | Impact of microRNA-34a and polymorphism of its target gene CA9 on susceptibility to uterine cervical cancer |
| Q104795151 | Interplay between p53 and non-coding RNAs in the regulation of EMT in breast cancer |
| Q55113967 | Long non-coding RNA linc01433 promotes migration and invasion in non-small cell lung cancer. |
| Q64119129 | MiR-409-3p Inhibits Cell Proliferation and Invasion of Osteosarcoma by Targeting Zinc-Finger E-Box-Binding Homeobox-1 |
| Q58548157 | MicroRNA-34 family in breast cancer: from research to therapeutic potential |
| Q44463289 | MicroRNA-34a: A Versatile Regulator of Myriads of Targets in Different Cancers. |
| Q64901416 | MicroRNA‑199a‑5p suppresses migration and invasion in oral squamous cell carcinoma through inhibiting the EMT‑related transcription factor SOX4. |
| Q92155499 | Nanomaterials as Inhibitors of Epithelial Mesenchymal Transition in Cancer Treatment |
| Q92383918 | Notch1 in Tumor Microvascular Endothelial Cells and Tumoral miR-34a as Prognostic Markers in Locally Advanced Triple-Negative Breast Cancer |
| Q64259767 | Roles of MicroRNA-34a in Epithelial to Mesenchymal Transition, Competing Endogenous RNA Sponging and Its Therapeutic Potential |
| Q91756222 | SOX9 promotes epithelial-mesenchymal transition via the Hippo-YAP signaling pathway in gastric carcinoma cells |
| Q93050433 | TSPAN9 and EMILIN1 synergistically inhibit the migration and invasion of gastric cancer cells by increasing TSPAN9 expression |
| Q33618617 | The diagnostic role of microRNA-34a in breast cancer: a systematic review and meta-analysis |
| Q47327997 | Thymoquinone Inhibits the Migration and Invasive Characteristics of Cervical Cancer Cells SiHa and CaSki In Vitro by Targeting Epithelial to Mesenchymal Transition Associated Transcription Factors Twist1 and Zeb1. |
| Q39403430 | Thymoquinone as a Potential Adjuvant Therapy for Cancer Treatment: Evidence from Preclinical Studies. |
| Q39295835 | Thymoquinone, as an anticancer molecule: from basic research to clinical investigation. |
| Q47139724 | miR-34a expression in human breast cancer is associated with drug resistance |
Search more.